» Articles » PMID: 24587880

Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population

Overview
Date 2014 Mar 4
PMID 24587880
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: FOS-like antigen-2 (FOSL-2), a member of the FOS gene family, encode leucine zipper proteins that can heterodimerize with proteins of Jun family. Thus, activating protein (AP)-1 transcription factor is formed, has a crucial role in proliferation, differentiation and apoptosis of normal tissue as well as oncogenic transformation and progression. We performed an association study of single nucleotide polymorphisms (SNPs) in the FOSL-2 with papillary thyroid cancer (PTC). We also estimated the relationships between the SNPs and the clinicopathologic characteristics of PTC.

Methods: One promoter SNPs (rs925255) of FOSL-2 gene were genotyped with direct sequencing method in 94 PTC and 213 controls. PTC patients were dichotomized and compared with respect to clinical parameters of PTC. Genetic data were analyzed using Helixtree, SNPAnalyzer, SNPStats. Multivariate logistic regression analysis was fulfilled to evaluate the genetic effect with adjustment for age and sex.

Results: SNP (rs925255) in FOSL-2 showed a significant association (codominant 1 model [G/G vs. A/G]: odds ratio [OR], 0.531, 95% confidence interval [CI], 0.293 to 0.96, P=0.036; dominant model: OR, 0.50, 95% CI, 0.28 to 0.89, P=0.015) with PTC. The frequency of allele G in rs925255 was also significantly associated with PTC (OR, 0.59; 95% CI, 0.34 to 0.91; P=0.02). But we fail to prove significant association between this polymorphism (rs925255) and clinico-pathological parameters.

Conclusion: Our findings suggest that the rs925255 SNP and its allele G show significant association with the PTC in Korean population.

Citing Articles

Signatures of Six Autophagy-Related Genes as Diagnostic Markers of Thyroid-Associated Ophthalmopathy and Their Correlation With Immune Infiltration.

Ma Q, Hai Y, Shen J Immun Inflamm Dis. 2024; 12(12):e70093.

PMID: 39660984 PMC: 11633049. DOI: 10.1002/iid3.70093.


Progress in the Study of Fra-2 in Respiratory Diseases.

Zheng S, Liu Y Int J Mol Sci. 2024; 25(13).

PMID: 39000247 PMC: 11240912. DOI: 10.3390/ijms25137143.

References
1.
Siraj A, Al-Rasheed M, Ibrahim M, Siddiqui K, Al-Dayel F, Al-Sanea O . RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. J Endocrinol Invest. 2008; 31(10):893-9. DOI: 10.1007/BF03346438. View

2.
Czene K, Lichtenstein P, Hemminki K . Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer. 2002; 99(2):260-6. DOI: 10.1002/ijc.10332. View

3.
Ozgen A, Karadeniz M, Erdogan M, Berdeli A, Saygili F, Yilmaz C . The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients. J Endocrinol Invest. 2009; 32(6):491-4. DOI: 10.1007/BF03346494. View

4.
Erdogan M, Karadeniz M, Ozbek M, Ozgen A, Berdeli A . Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population. J Endocrinol Invest. 2008; 31(9):750-4. DOI: 10.1007/BF03349252. View

5.
Bakiri L, Matsuo K, Wisniewska M, Wagner E, Yaniv M . Promoter specificity and biological activity of tethered AP-1 dimers. Mol Cell Biol. 2002; 22(13):4952-64. PMC: 133900. DOI: 10.1128/MCB.22.13.4952-4964.2002. View